Ziprasidone
Closed Pre-Solicitation Posted
- Solicitation number
- SPE2D2-19-R-0045
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency plans to issue a solicitation for a national requirements contract to supply ziprasidone hydrochloride capsules in 20mg, 40mg, 60mg, and 80mg dosages packaged in 60 count bottles. The contract will have a one year base period and four one year option periods, utilizing a firm-fixed price and requirements type structure. Annual usage estimates will be provided in the solicitation's schedule of supplies. As an unrestricted commercial item acquisition conducted under FAR Part 12, all sources may submit proposals that will be considered without using an evaluation criteria. Interested parties should contact the named point of contact with any questions in advance of the projected May 2019 solicitation date.
There is no set-aside designation for this procurement. The NAICS code is 325412, Pharmaceutical Preparation Manufacturing, and the PSC code is 6505, Drugs (Pharmaceutical Preparations). The incumbent contractor is Golden State Medical Supply, Inc. No award values or budget ranges were provided, but the contract will establish a national supply source for the listed pharmaceutical items to be purchased on an annual basis by the Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons through prime vendor programs.
Notice text
2 versions
Update #2 · Latest ·
Ziprasidone
Update #1 ·
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Ziprasidone. Procurement details follow.
Ziprasidone HCL 20MG, 40MG, 60Mg, and 80MG capsules in 60 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and FEDBIZOPS at https://www.fbo.gov. Interested parties should contact Catherine Gilbert (215-737-4778) (catherine.gilbert@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is May of 2019. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Files
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Methylphenidate ER | Medical Supply Chain | No set-aside | |
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity